Vita Sentry

Company Overview

Snapshot

Founded in June 2011 by Elon Rachman and Reuven Gladshtein, Vita Sentry operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on the development of its noninvasive optical technology.

Business overview

Vita Sentry develops noninvasive optical technology designed to measure the inner diameter, cross-section, degree of change, and stiffness of small blood vessels (arterioles). This technology monitors peripheral vascular resistance for immediate diagnosis of various significant health conditions, including hemorrhage, dehydration, changes in arterial blood pressure, stress conditions, arrhythmia, diabetic foot issues, and atherosclerosis. The company aims to provide a low-cost solution for early diagnosis of numerous health pathologies, serving private customers for infant and senior dehydration, and fitness and sports practitioners for real-time vascular condition tracking. Vita Sentry operates within the Health Tech & Life Sciences sector, specifically in Medical Devices, Diagnostics Devices, and Medical Monitors.

Company Intelligence Q&A

What is Vita Sentry's core technology?

Vita Sentry has developed a noninvasive optical technology that measures the inner diameter, cross-section, degree of change, and stiffness of small blood vessels (arterioles).

What health conditions can Vita Sentry's technology help diagnose?

The technology monitors peripheral vascular resistance for immediate diagnosis of conditions such as hemorrhage, dehydration, changes in arterial blood pressure, various stress conditions, arrhythmia, diabetic foot issues, and atherosclerosis.

Who are the target customers for Vita Sentry's solutions?

Vita Sentry targets private customers for early diagnosis of dehydration in infants or seniors, and fitness and sports practitioners for tracking real-time vascular conditions.

When was Vita Sentry founded and by whom?

Vita Sentry was founded in June 2011 by Elon Rachman and Reuven Gladshtein.

What is Vita Sentry's product development stage?

Vita Sentry's product is currently in the Research & Development (R&D) stage, focusing on advancing its noninvasive optical technology.